EPIDEMIOLOGY OF HEAD AND NECK-CANCER - THE CLINICIANS CONTRIBUTION

被引：2

作者：

MORTON, RP

机构：

来源：

CLINICAL OTOLARYNGOLOGY | 1989年 / 14卷 / 04期

关键词：

D O I：

10.1111/j.1365-2273.1989.tb00373.x

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

引用

页码：279 / 280

页数：2

共 50 条

[41] CHEMOTHERAPY OF HEAD AND NECK-CANCER
KIES, MS
LEVITAN, N
HONG, WK
[J]. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1985, 18 (03) : 533 - 541
[42] VICISSITUDES OF HEAD AND NECK-CANCER
MADDOX, WA
[J]. AMERICAN JOURNAL OF SURGERY, 1984, 148 (04): : 428 - 432
[43] CYTOGENETICS IN HEAD AND NECK-CANCER
COWAN, JM
[J]. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1992, 25 (05) : 1073 - 1087
[44] ADVANCED HEAD AND NECK-CANCER
ORDONEZ, A
CHACON, JI
[J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1991, 84 (01) : 59 - 59
[45] CHEMOTHERAPY TRIALS IN HEAD AND NECK-CANCER
MERLANO, M
[J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1995, 17 (03): : 266 - 267
[46] THE RISK TO THE ORBIT IN HEAD AND NECK-CANCER
CONLEY, J
[J]. LARYNGOSCOPE, 1985, 95 (05): : 515 - 522
[47] MANAGEMENT OF RECURRENT HEAD AND NECK-CANCER
KRESPI, YP
WURSTER, CF
SISSON, GA
[J]. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1985, 18 (03) : 613 - 619
[48] ADJUVANT CHEMOTHERAPY IN HEAD AND NECK-CANCER
STELL, PM
RAWSON, NSB
[J]. BRITISH JOURNAL OF CANCER, 1990, 61 (05) : 779 - 787
[49] LONIDAMINE AND RADIOTHERAPY IN HEAD AND NECK-CANCER
MAGNO, L
TERRANEO, F
BERTONI, F
TORDIGLIONE, M
BARDELLI, D
DEGREGORIO, M
CIOTTOLI, GB
[J]. BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 541 - 541
[50] INTRAARTERIAL CHEMOTHERAPY FOR HEAD AND NECK-CANCER
INUYAMA, Y
[J]. CANCER CHEMOTHERAPY : CHALLENGES FOR THE FUTURE, VOL 4, 1989, 904 : 133 - 138